ロード中...
Why maximum tolerated dose?
A long‐established approach to the pharmacological treatment of disease has been to start low and go slow. However, clinicians often prescribe up to maximum tolerated dose (MTD), especially when treating acute and more severe disease, without evidence to show that MTD is more likely to improve outco...
保存先:
| 出版年: | Br J Clin Pharmacol |
|---|---|
| 主要な著者: | , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
John Wiley and Sons Inc.
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6783596/ https://ncbi.nlm.nih.gov/pubmed/31219196 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bcp.14032 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|